Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Invested Capital: 2016-2025

Historic Return on Invested Capital for ImmunityBio (IBRX) over the last 6 years, with Sep 2025 value amounting to 0.48%.

  • ImmunityBio's Return on Invested Capital was N/A to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year change of. This contributed to the annual value of 25.91% for FY2023, which is N/A change from last year.
  • According to the latest figures from Q3 2025, ImmunityBio's Return on Invested Capital is 0.48%, which was up 121.81% from -2.18% recorded in Q1 2025.
  • In the past 5 years, ImmunityBio's Return on Invested Capital registered a high of 1.73% during Q2 2021, and its lowest value of -2.18% during Q1 2025.
  • Its 2-year average for Return on Invested Capital is 0.01%, with a median of 0.48% in 2025.
  • Data for ImmunityBio's Return on Invested Capital shows a maximum YoY plummeted of 7,229bps (in 2021) over the last 5 years.
  • Over the past 3 years, ImmunityBio's Return on Invested Capital (Quarterly) stood at 1.55% in 2021, then followed by 1.72% in 2023, then followed by 0.48% in 2025.
  • Its Return on Invested Capital was 0.48% in Q3 2025, compared to -2.18% in Q1 2025 and 1.72% in Q4 2023.